Ceramides – Lipotoxic Inducers of Metabolic Disorders
Tóm tắt
Từ khóa
Tài liệu tham khảo
Unger, 1995, Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications, Diabetes, 44, 863, 10.2337/diab.44.8.863
Lee, 1994, Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte–beta-cell relationships, Proc. Natl. Acad. Sci. U.S.A., 91, 10878, 10.1073/pnas.91.23.10878
Unger, 2010, Lipid homeostasis, lipotoxicity and the metabolic syndrome, Biochim. Biophys. Acta, 1801, 209, 10.1016/j.bbalip.2009.10.006
Shulman, 2014, Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease, N. Engl. J. Med., 371, 1131, 10.1056/NEJMra1011035
Shimabukuro, 1998, Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression, J. Biol. Chem., 273, 32487, 10.1074/jbc.273.49.32487
Holland, 2007, Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance, Cell Metab., 5, 167, 10.1016/j.cmet.2007.01.002
Bismuth, 2008, Ceramide: a common pathway for atherosclerosis?, Atherosclerosis, 196, 497, 10.1016/j.atherosclerosis.2007.09.018
Chavez, 2012, A ceramide-centric view of insulin resistance, Cell Metab., 15, 585, 10.1016/j.cmet.2012.04.002
Bikman, 2012, Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis, J. Biol. Chem., 287, 17426, 10.1074/jbc.M112.359950
Holland, 2011, Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice, J. Clin. Invest., 121, 1858, 10.1172/JCI43378
Bikman, 2011, Ceramides as modulators of cellular and whole-body metabolism, J. Clin. Invest., 121, 4222, 10.1172/JCI57144
Summers, 2010, Sphingolipids and insulin resistance: the five Ws, Curr. Opin. Lipidol., 21, 128, 10.1097/MOL.0b013e3283373b66
Zhang, 2012, Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS–Akt complex, Diabetes, 61, 1848, 10.2337/db11-1399
Hojjati, 2005, Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice, J. Biol. Chem., 280, 10284, 10.1074/jbc.M412348200
Park, 2012, Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure, Heart Fail. Clin., 8, 633, 10.1016/j.hfc.2012.06.003
Lee, 2012, Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction, J. Biol. Chem., 287, 18429, 10.1074/jbc.M111.296947
Jiang, 2011, Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy, Adv. Exp. Med. Biol., 721, 19, 10.1007/978-1-4614-0650-1_2
Park, 2008, Ceramide is a cardiotoxin in lipotoxic cardiomyopathy, J. Lipid Res., 49, 2101, 10.1194/jlr.M800147-JLR200
Nikolova-Karakashian, 2010, Ceramide in stress response, Adv. Exp. Med. Biol., 688, 86, 10.1007/978-1-4419-6741-1_6
Zeidan, 2007, Translational aspects of sphingolipid metabolism, Trends Mol. Med., 13, 327, 10.1016/j.molmed.2007.06.002
Hanada, 2009, CERT-mediated trafficking of ceramide, Biochim. Biophys. Acta, 1791, 684, 10.1016/j.bbalip.2009.01.006
Claus, 2009, Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate, Curr. Med. Chem., 16, 1978, 10.2174/092986709788682182
Kitatani, 2009, Involvement of acid beta-glucosidase 1 in the salvage pathway of ceramide formation, J. Biol. Chem., 284, 12972, 10.1074/jbc.M802790200
Adams, 2004, Ceramide content is increased in skeletal muscle from obese insulin-resistant humans, Diabetes, 53, 25, 10.2337/diabetes.53.1.25
Amati, 2011, Skeletal-muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?, Diabetes, 60, 2588, 10.2337/db10-1221
Dube, 2008, Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited, Am. J. Physiol. Endocrinol. Metab., 294, E882, 10.1152/ajpendo.00769.2007
Dube, 2011, Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide, Diabetologia, 54, 1147, 10.1007/s00125-011-2065-0
de Mello, 2009, Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease, Diabetologia, 52, 2612, 10.1007/s00125-009-1482-9
Haus, 2009, Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance, Diabetes, 58, 337, 10.2337/db08-1228
Brozinick, 2013, Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet, Int. J. Obes., 37, 1064, 10.1038/ijo.2012.191
Galbo, 2013, Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo, Proc. Natl. Acad. Sci. U.S.A., 110, 12780, 10.1073/pnas.1311176110
Nowotny, 2013, Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans, Diabetes, 62, 2240, 10.2337/db12-1179
Chavez, 2003, Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes, Arch. Biochem. Biophys., 419, 101, 10.1016/j.abb.2003.08.020
Hu, 2009, Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity, J. Lipid Res., 50, 1852, 10.1194/jlr.M800635-JLR200
Hu, 2011, Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance, J. Biol. Chem., 286, 16596, 10.1074/jbc.M110.186916
Shi, 2006, TLR4 links innate immunity and fatty acid-induced insulin resistance, J. Clin. Invest., 116, 3015, 10.1172/JCI28898
Majumdar, 2012, Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome, Endocrine, 41, 442, 10.1007/s12020-011-9589-4
Kim, 2001, Prevention of fat-induced insulin resistance by salicylate, J. Clin. Invest., 108, 437, 10.1172/JCI11559
Cai, 2005, Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB, Nat. Med., 11, 183, 10.1038/nm1166
Sims, 2010, Kdo2-lipid A, a TLR4-specific agonist, induces de novo sphingolipid biosynthesis in RAW264.7 macrophages, which is essential for induction of autophagy, J. Biol. Chem., 285, 38568, 10.1074/jbc.M110.170621
Schilling, 2013, Palmitate and lipopolysaccharide trigger synergistic ceramide production in primary macrophages, J. Biol. Chem., 288, 2923, 10.1074/jbc.M112.419978
Goldberg, 2015, Drivers of age-related inflammation and strategies for healthspan extension, Immunol. Rev., 265, 63, 10.1111/imr.12295
Vandanmagsar, 2011, The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance, Nat. Med., 17, 179, 10.1038/nm.2279
Youm, 2011, Elimination of the NLRP3–ASC inflammasome protects against chronic obesity-induced pancreatic damage, Endocrinology, 152, 4039, 10.1210/en.2011-1326
Turer, 2012, Adiponectin: mechanistic insights and clinical implications, Diabetologia, 55, 2319, 10.1007/s00125-012-2598-x
Kim, 2007, Obesity-associated improvements in metabolic profile through expansion of adipose tissue, J. Clin. Invest., 117, 2621, 10.1172/JCI31021
Hardie, 2015, AMPK: positive and negative regulation, and its role in whole-body energy homeostasis, Curr. Opin. Cell Biol., 33, 1, 10.1016/j.ceb.2014.09.004
Holland, 2009, PAQRs: a counteracting force to ceramides?, Mol. Pharmacol., 75, 740, 10.1124/mol.109.054817
Holland, 2011, Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin, Nat. Med., 17, 55, 10.1038/nm.2277
Kharitonenkov, 2011, FGF21 reloaded: challenges of a rapidly growing field, Trends Endocrinol. Metab., 22, 81, 10.1016/j.tem.2010.11.003
Holland, 2013, An FGF21–adiponectin–ceramide axis controls energy expenditure and insulin action in mice, Cell Metab., 17, 790, 10.1016/j.cmet.2013.03.019
Backhed, 2004, The gut microbiota as an environmental factor that regulates fat storage, Proc. Natl. Acad. Sci. U.S.A., 101, 15718, 10.1073/pnas.0407076101
Jiang, 2014, Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease, J. Clin. Invest., 125, 386, 10.1172/JCI76738
Chavez, 2010, Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms, Biochim. Biophys. Acta, 1801, 252, 10.1016/j.bbalip.2009.09.015
Summers, 1998, Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide, Mol. Cell. Biol., 18, 5457, 10.1128/MCB.18.9.5457
Stratford, 2004, Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B, J. Biol. Chem., 279, 36608, 10.1074/jbc.M406499200
Powell, 2003, Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism, Mol. Cell. Biol., 23, 7794, 10.1128/MCB.23.21.7794-7808.2003
Hajduch, 2008, Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide, Biochem. J., 410, 369, 10.1042/BJ20070936
Chavez, 2005, Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling, J. Biol. Chem., 280, 20148, 10.1074/jbc.M412769200
Watson, 2009, Modulating serine palmitoyl transferase (SPT) expression and activity unveils a crucial role in lipid-induced insulin resistance in rat skeletal muscle cells, Biochem. J., 417, 791, 10.1042/BJ20081149
Yang, 2009, Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome, Am. J. Physiol. Endocrinol. Metab., 297, E211, 10.1152/ajpendo.91014.2008
Ussher, 2010, Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption, Diabetes, 59, 2453, 10.2337/db09-1293
Fillmore, 2015, Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat, Exp. Physiol., 100, 730, 10.1113/EP085052
Dekker, 2013, Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction, Atherosclerosis, 228, 98, 10.1016/j.atherosclerosis.2013.01.041
Turpin, 2014, Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance, Cell Metab., 20, 678, 10.1016/j.cmet.2014.08.002
Li, 2011, Reducing plasma membrane sphingomyelin increases insulin sensitivity, Mol. Cell. Biol., 31, 4205, 10.1128/MCB.05893-11
Boon, 2013, Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance, Diabetes, 62, 401, 10.2337/db12-0686
Tagami, 2002, Ganglioside GM3 participates in the pathological conditions of insulin resistance, J. Biol. Chem., 277, 3085, 10.1074/jbc.M103705200
Yamashita, 2003, Enhanced insulin sensitivity in mice lacking ganglioside GM3, Proc. Natl. Acad. Sci. U.S.A., 100, 3445, 10.1073/pnas.0635898100
Fuller, 2010, Sphingolipids: the nexus between Gaucher disease and insulin resistance, Lipids Health Dis., 9, 113, 10.1186/1476-511X-9-113
Langeveld, 2008, Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance, J. Clin. Endocrinol. Metab., 93, 845, 10.1210/jc.2007-1702
Aerts, 2007, Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity, Diabetes, 56, 1341, 10.2337/db06-1619
Bijl, 2009, Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice, Hepatology, 50, 1431, 10.1002/hep.23175
van Eijk, 2009, Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation, PLoS ONE, 4, e4723, 10.1371/journal.pone.0004723
Chavez, 2014, Ceramides and glucosylceramides are independent antagonists of insulin signaling, J. Biol. Chem., 289, 723, 10.1074/jbc.M113.522847
Kim, 2008, Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome, Cleveland Clin. J. Med., 75, 721, 10.3949/ccjm.75.10.721
Correnti, 2014, Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice, Am. J. Physiol. Gastrointest. Liver Physiol., 306, G959, 10.1152/ajpgi.00395.2013
Kurek, 2014, Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease, Liver Int., 34, 1074, 10.1111/liv.12331
Raichur, 2014, CerS2 haploinsufficiency inhibits beta-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance, Cell Metab., 20, 687, 10.1016/j.cmet.2014.09.015
Hla, 2014, C16:0-ceramide signals insulin resistance, Cell Metab., 20, 703, 10.1016/j.cmet.2014.10.017
Di Paola, 2000, Ceramide interaction with the respiratory chain of heart mitochondria, Biochemistry, 39, 6660, 10.1021/bi9924415
Xia, 2015, Targeted induction of ceramide degradation reveals roles for cermaides in non alcoholic fatty liver disease and glucose metabolism in mice, Cell Metab., 22, 266, 10.1016/j.cmet.2015.06.007
El-Assaad, 2003, Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death, Endocrinology, 144, 4154, 10.1210/en.2003-0410
Lang, 2011, Ceramide formation as a target in beta-cell survival and function, Expert Opin. Ther. Targets, 15, 1061, 10.1517/14728222.2011.588209
Boslem, 2011, A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking, Biochem. J., 435, 267, 10.1042/BJ20101867
Kelpe, 2003, Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis, J. Biol. Chem., 278, 30015, 10.1074/jbc.M302548200
Guo, 2010, Blockage of ceramide metabolism exacerbates palmitate inhibition of pro-insulin gene expression in pancreatic beta-cells, Mol. Cell. Biochem., 338, 283, 10.1007/s11010-009-0362-4
Summers, 2005, A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome, Diabetes, 54, 591, 10.2337/diabetes.54.3.591
Park, 2004, Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice, Circulation, 110, 3465, 10.1161/01.CIR.0000148370.60535.22
Park, 2008, Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice, Pharmacol. Res., 58, 45, 10.1016/j.phrs.2008.06.005
Dong, 2006, Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice, J. Lipid Res., 47, 1307, 10.1194/jlr.M600040-JLR200
Li, 2012, Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice, Arterioscler. Thromb. Vasc. Biol., 32, 1577, 10.1161/ATVBAHA.112.251538
Glaros, 2008, Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice, J. Lipid Res., 49, 1677, 10.1194/jlr.E800005-JLR200
Kasumov, 2015, Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis, PLoS ONE, 10, e0126910, 10.1371/journal.pone.0126910
Walters, 2008, Effect of sphingomyelinase-mediated generation of ceramide on aggregation of low-density lipoprotein, Langmuir, 24, 9642, 10.1021/la800714w
Walters, 2011, Mechanistic roles of lipoprotein lipase and sphingomyelinase in low density lipoprotein aggregation, J. Colloid Interface Sci., 363, 268, 10.1016/j.jcis.2011.07.072
Li, 2014, Endogenous ceramide contributes to the transcytosis of oxLDL across endothelial cells and promotes its subendothelial retention in vascular wall, Oxid. Med. Cell. Longev., 2014, 823071, 10.1155/2014/823071
Gao, 2012, Palmitate promotes monocyte atherogenicity via de novo ceramide synthesis, Free Radic. Biol. Med., 53, 796, 10.1016/j.freeradbiomed.2012.05.026
Wu, 2007, Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase, J. Biol. Chem., 282, 9777, 10.1074/jbc.M608310200
Kronke, 1999, Biophysics of ceramide signaling: interaction with proteins and phase transition of membranes, Chem. Phys. Lipids, 101, 109, 10.1016/S0009-3084(99)00059-6
Murohara, 1996, Effects of sphingomyelinase and sphingosine on arterial vasomotor regulation, J. Lipid Res., 37, 1601, 10.1016/S0022-2275(20)39142-2
Bischoff, 2000, Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner, Br. J. Pharmacol., 130, 1878, 10.1038/sj.bjp.0703516
Bolz, 2003, Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase, Circulation, 108, 342, 10.1161/01.CIR.0000080324.12530.0D
Goldberg, 2012, Lipid metabolism and toxicity in the heart, Cell Metab., 15, 805, 10.1016/j.cmet.2012.04.006
Russo, 2012, Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes, J. Clin. Invest., 122, 3919, 10.1172/JCI63888
Liu, 2011, Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin, Nephrol. Dial. Transplant., 26, 1493, 10.1093/ndt/gfq633
Itoh, 2006, Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury, Kidney Int., 69, 288, 10.1038/sj.ki.5000057
Basnakian, 2005, Ceramide synthase is essential for endonuclease-mediated death of renal tubular epithelial cells induced by hypoxia-reoxygenation, Am. J. Physiol. Renal Physiol., 288, F308, 10.1152/ajprenal.00204.2004
Denis, 2002, Advanced glycation end-products induce apoptosis of bovine retinal pericytes in culture: involvement of diacylglycerol/ceramide production and oxidative stress induction, Free Radic. Biol. Med., 33, 236, 10.1016/S0891-5849(02)00879-1
Cacicedo, 2005, Palmitate-induced apoptosis in cultured bovine retinal pericytes: roles of NAD(P)H oxidase, oxidant stress, and ceramide, Diabetes, 54, 1838, 10.2337/diabetes.54.6.1838
Deevska, 2009, Acid sphingomyelinase deficiency prevents diet-induced hepatic triacylglycerol accumulation and hyperglycemia in mice, J. Biol. Chem., 284, 8359, 10.1074/jbc.M807800200
Yetukuri, 2007, Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis, BMC Syst. Biol., 1, 12, 10.1186/1752-0509-1-12
Benoit, 2009, Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents, J. Clin. Invest., 119, 2577, 10.1172/JCI36714
Contreras, 2014, Central ceramide-induced hypothalamic lipotoxicity and ER stress regulate energy balance, Cell Rep., 9, 366, 10.1016/j.celrep.2014.08.057
Chun, 2011, Inhibition of ceramide synthesis reverses endothelial dysfunction and atherosclerosis in streptozotocin-induced diabetic rats, Diab. Res. Clin. Pract., 93, 77, 10.1016/j.diabres.2011.03.017
Sjoholm, 1995, Ceramide inhibits pancreatic beta-cell insulin production and mitogenesis and mimics the actions of interleukin-1 beta, FEBS Lett., 367, 283, 10.1016/0014-5793(95)00470-T